Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells

Toxicology and Applied Pharmacology
G Dirami, B A Cooke

Abstract

Dopamine agonists are known to increase the incidence of Leydig cell hyperplasia/adenomas when administered to rats over periods of 1-2 years. We have examined the early changes in factors affecting luteinizing hormone (LH)-controlled signal transduction pathways and steroidogenesis in Leydig cells in vitro after chronic oral administration of one of these dopamine agonists, Mesulergine (CU327-085) (N-(1-6,dimethylergolin-8a-yl)-N',N'-dimethylsulphamide hydrochloride) to Sprague-Dawley (SD) rats. Eight-week-old rats were given this dopamine agonist (2 mg/kg body wt/day) in food for 1, 5, or 12 weeks. The Leydig cells from control and treated rats were purified by elutriation and density gradient centrifugation. The dopamine agonist treatment was found to decrease the specific binding of 125I-human chorionic gonadotrophin (hCG) binding to the Leydig cells: a decrease was detected as early as 1 week after treatment and was more pronounced after 5 and 12 weeks. This was found to be due to a decrease in the LH/hCG receptor numbers and not to a decrease in LH/hCG-receptor binding affinity. Both basal and LH-stimulated cAMP and testosterone production were also decreased; cAMP production was decreased by approximately 50% by all conc...Continue Reading

References

Aug 1, 1979·Endocrinology·L E Valladares, A H Payne
Jan 1, 1992·Archives of Toxicology. Supplement. = Archiv Für Toxikologie. Supplement·D E PrenticeR A Ettlin
Sep 1, 1991·The Journal of Endocrinology·G DiramiB A Cooke
Jan 1, 1991·The Journal of Steroid Biochemistry and Molecular Biology·B A CookeL Phipp
Dec 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C Monder
Apr 1, 1987·Endocrinology·G P OrczykC Longcope
Mar 1, 1988·Journal of Steroid Biochemistry·C H Tsai-MorrisM L Dufau
Jan 1, 1985·Experimental Aging Research·A BartkeP C Doherty
Mar 1, 1980·The Journal of Clinical Investigation·S B CigorragaM L Dufau
Apr 1, 1981·Acta Endocrinologica·O P ClausenV Hansson
Oct 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·D A Freeman, M Ascoli
Jan 1, 1982·The Journal of Endocrinology·E A Zylber-HaranI M Spitz
Dec 1, 1981·Journal of Steroid Biochemistry·K PurvisV Hansson
Jan 1, 1980·Journal of Steroid Biochemistry·W H Moger
Nov 1, 1980·Biology of Reproduction·A O BrinkmannH J Van der Molen
Jul 1, 1995·Human & Experimental Toxicology·D E Prentice, A W Meikle
Sep 1, 1995·Toxicology and Applied Pharmacology·L B BiegelJ C Cook
May 1, 1993·The Journal of Toxicological Sciences·S HosokawaJ Miyamoto
Apr 1, 1993·Toxicology and Applied Pharmacology·J C CookL B Biegel
Jan 1, 1997·Reproductive Toxicology·E D CleggG P Daston
Dec 28, 1971·Biochimica Et Biophysica Acta·J I Thorell, B G Johansson
Aug 15, 1972·FEBS Letters·F F.G. RommertsH J. van der Molen

❮ Previous
Next ❯

Citations

Apr 20, 2001·British Journal of Pharmacology·J J ChenS W Wang
Jul 5, 2019·Reproduction, Fertility, and Development·E S A M SanchesM J S Salles
May 2, 2003·Journal of Animal Science·H Jiménez-SeverianoJ E Kinder
May 2, 2019·Reproduction, Fertility, and Development·Eliane S A M SanchesMaria J S Salles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biosynthetic Transformations

Biosyntheic transformtions are multi-step, enzyme-catalyzed processes where substrates are converted into more complex products in living organisms. Simple compounds are modified, converted into other compounds, or joined together to form macromolecules. Discover the latest research on biosynthetic transformations here.